{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:17:50Z","timestamp":1790115470252,"version":"4.0.1"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>This study aimed to assess the therapeutic effects and underlying mechanisms of topical fluoxetine application in an atopic dermatitis (AD)\u2010like mouse model. An AD\u2010like mouse model was established using 2,4\u2010dinitrochlorobenzene (DNCB) and treated with topical applications of fluoxetine on skin lesions. The therapeutic efficacy was evaluated by measuring the number of scratches, skin thickness, trans\u2010epidermal water loss (TEWL), and skin moisture levels. Histopathological changes were examined through haematoxylin and eosin staining and toluidine blue staining to assess the local inflammatory state. Quantitative PCR (qPCR) was used to measure the expression of Th2\u2010related cytokines (IL\u20105, IL\u201013, and IL\u201031) in skin lesions. Serum levels of IgE and thymus\u2010 and activation\u2010regulated chemokine (TARC) were measured by enzyme\u2010linked immunosorbent assay (ELISA). Topical fluoxetine significantly alleviated lesion symptoms in AD\u2010like mice, reducing skin thickness and the number of scratching incidents. The treatment enhanced skin barrier recovery and reduced the infiltration of inflammatory cells, especially mast cells. Levels of Th2\u2010related cytokines (IL\u20105, IL\u201013, and IL\u201031), indicative of local immune status, were also decreased. Serum concentrations of IgE and TARC showed a downward trend, with a more pronounced decrease in TARC levels. Our findings support the therapeutic role of topical fluoxetine in an AD\u2010like mouse model through the repair of the skin barrier and inhibition of the Th2 inflammatory response in skin lesions, while also alleviating pruritus. These results suggest that fluoxetine may be a potential therapeutic candidate for AD.<\/jats:p>","DOI":"10.1111\/exd.70096","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T02:26:32Z","timestamp":1745547992000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Topical Application of Fluoxetine Improves <scp>DNCB<\/scp>\u2010Induced Atopic Dermatitis in Mice"],"prefix":"10.1111","volume":"34","author":[{"given":"Xue","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Dermatology Chongqing Tranditional Chinese Medicine Hospital  Chongqing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8382-6005","authenticated-orcid":false,"given":"Xiaobin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Paediatrics Chongqing Health Center for Women and Children  Chongqing China"},{"name":"Chongqing Medical University Women and Children's Hospital of Chongqing Medical University  Chongqing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology Chongqing Tranditional Chinese Medicine Hospital  Chongqing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology Chongqing Tranditional Chinese Medicine Hospital  Chongqing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.11.015"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.10.043"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.4566"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9899.1000110"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00774.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12112"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2021.06.005"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-017-0487-1"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b19-00088"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-021-01305-x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.14-0173"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052618"},{"issue":"2","key":"e_1_2_8_14_1","first-page":"4","article-title":"Crisaborole 2% Ointment (Eucrisa) for Atopic Dermatitis","volume":"24","author":"Woo T. E.","year":"2019","journal-title":"Skin Therapy Letter"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2008.04.003"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1415"},{"issue":"75","key":"e_1_2_8_17_1","first-page":"1","article-title":"Systematic Review of Published Trials: Long\u2010Term Safety of Topical Corticosteroids and Topical Calcineurin Inhibitors in Pediatric Patients With Atopic Dermatitis","volume":"16","author":"Siegfried E. C.","year":"2016","journal-title":"BMC Pediatrics"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.41378"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852913000576"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00318"},{"issue":"2","key":"e_1_2_8_21_1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.164.2.249","article-title":"Beneficial Sexual Side\u2010Effects From Fluoxetine","volume":"164","author":"Power\u2010Smith P.","year":"1994","journal-title":"British Journal of Psychiatry: The Journal of Mental Science"},{"issue":"15","key":"e_1_2_8_22_1","first-page":"5026","article-title":"The First Male Case With Fluoxetine Induced Hair Loss and Review of the Literature","volume":"25","author":"Aky\u00fcz Karacan F.","year":"2021","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"6","key":"e_1_2_8_23_1","article-title":"Akathisia as an Extrapyramidal Side Effect of Fluoxetine","volume":"13","author":"Ajufo I.","year":"2021","journal-title":"Cureus"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.3.5.495"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-021-00367-5"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2019.82821"},{"issue":"282","key":"e_1_2_8_27_1","first-page":"217","article-title":"A the Level of Total Immunoglobulin E as an Indicator of Disease Grade in Adults With Severe Atopic Dermatitis","volume":"47","author":"Jaworek A. K.","year":"2019","journal-title":"Polski Merkuriusz Lekarski"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2010.02.008"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/vde.12894"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2004.02.001"}],"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/exd.70096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T11:26:46Z","timestamp":1755689206000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/exd.70096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1111\/exd.70096"],"URL":"https:\/\/doi.org\/10.1111\/exd.70096","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70096"}}